31
TITLE: Chemical Patterns of Proteasome Inhibitors: Lessons Learned from Two Decades of Drug Design
AUTHORS: Guedes, RA; Aniceto, N; Andrade, MAP; Salvador, JAR; Guedes, RC;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 20, ISSUE: 21
INDEXED IN: Scopus WOS CrossRef: 9 Handle
IN MY: ORCID
32
TITLE: An overview of glutaminyl cyclase inhibitors for Alzheimer's disease
AUTHORS: Coimbra, JRM; Sobral, PJM; Santos, AE; Moreira, PI; Moreira, Paula Isabel; Paula I. Moreira ; Salvador, JAR;
PUBLISHED: 2019, SOURCE: FUTURE MEDICINAL CHEMISTRY, VOLUME: 11, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
33
TITLE: Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling
AUTHORS: Valdeira, ASC; Ritt, DA; Morrison, DK; McMahon, JB; Gustafson, KR; Salvador, JAR;
PUBLISHED: 2018, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 6
INDEXED IN: WOS CrossRef: 5
IN MY: ORCID
34
TITLE: Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy
AUTHORS: Acurcio, RC; Scomparin, A; Conniot, J; Salvador, JAR; Satchi Fainaro, R; Florindo, HF; Guedes, RC;
PUBLISHED: 2018, SOURCE: JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 61, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef: 31
IN MY: ORCID
35
TITLE: Highlights in BACE1 inhibitors for Alzheimer's disease treatment
AUTHORS: Judite R M Coimbra; Daniela F F Marques; Salete J Baptista; Cláudia M F Pereira; Paula I Moreira; Teresa C P Dinis; Armanda E Santos; Jorge A R Salvador;
PUBLISHED: 2018, SOURCE: Frontiers in Chemistry, VOLUME: 6, ISSUE: MAY
INDEXED IN: Scopus CrossRef: 126
IN MY: ORCID
36
TITLE: Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach
AUTHORS: Baptista, SJ; Silva, MMC; Moroni, E; Meli, M; Colombo, G; Dinis, TCP; Salvador, JAR;
PUBLISHED: 2017, SOURCE: PLOS ONE, VOLUME: 12, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 14
IN MY: ORCID
37
TITLE: Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds
AUTHORS: Figueiredo, SAC; Salvador, JAR; Cortés, R; Cascante, M;
PUBLISHED: 2017, SOURCE: European Journal of Medicinal Chemistry, VOLUME: 139
INDEXED IN: Scopus CrossRef: 25
IN MY: ORCID
38
TITLE: Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation
AUTHORS: Figueiredo, SAC; Salvador, JAR; Cortes, R; Cascante, M;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 138
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
39
TITLE: Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
AUTHORS: Salvador, JAR; Leal, AS; Valdeira, AS; Goncalves, BMF; Alho, DPS; Figueiredo, SAC; Silvestre, SM; Mendes, VIS;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 142
INDEXED IN: Scopus WOS CrossRef: 122
IN MY: ORCID
40
TITLE: Synthesis and biological evaluation of novel asiatic acid derivatives with anticancer activity
AUTHORS: Gonçalves, BMF; Salvador, JAR; Marín, S; Cascante, M;
PUBLISHED: 2016, SOURCE: RSC Advances, VOLUME: 6, ISSUE: 5
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 4 of 9. Total results: 84.